loader
Please Wait
Applying Filters...

Quotient Sciences Quotient Sciences

X

Approved Drug Products containing 211810 listed in the FDA Orange Book. Original Data : FDA Website

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 DAIICHI SANKYO INC (2)

filter

01 CAPSULE;ORAL (2)

filter

01 DISCN (1)

02 RX (1)

filter

01 TURALIO (2)

filter

01 Yes (2)

URL Supplier Web Content
CAPSULE; ORAL
EQ 200MG BASE
2019-08-02
211810
TURALIO
DISCN
Yes
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
CAPSULE; ORAL
EQ 125MG BASE
2022-10-14
211810
TURALIO
RX
Yes
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for FDA Orange Book APPLICATION 211810

Looking for FDA Orange Book APPLICATION 211810 2

19

Daiichi Sankyo, based in Japan, is a pharmaceutical company that stands out with its certifications from FDA.

One of their notable products is PEXIDARTINIB HYDROCHLORIDE, with a corresponding application number 211810.

Regulatory Information DISCN

With a dosage strength EQ 200MG BASE

Dosage Form Route CAPSULE; ORAL

Reference Listed Drug Yes

Approved since 2019-08-02

18

Daiichi Sankyo, based in Japan, is a pharmaceutical company that stands out with its certifications from FDA.

One of their notable products is PEXIDARTINIB HYDROCHLORIDE, with a corresponding application number 211810.

Regulatory Information RX

With a dosage strength EQ 125MG BASE

Dosage Form Route CAPSULE; ORAL

Reference Listed Drug Yes

Approved since 2022-10-14

Post Enquiry
POST ENQUIRY